BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee CH, Lin YJ, Lin CC, Yen CL, Shen CH, Chang CJ, Hsieh SY. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma. Liver Int. 2015;35:2327-2336. [PMID: 25752212 DOI: 10.1111/liv.12817] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Hsieh S, Lee C, Yen C, Shen C. Reply to Pang et al . letter: Multifaceted roles of platelets in the prognosis of patients with hepatoma. Liver Int 2015;35:2485-2485. [DOI: 10.1111/liv.12870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Tao Y, Li Y, Liu X, Deng Q, Yu Y, Yang Z. Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis. Cancer Manag Res. 2018;10:2695-2709. [PMID: 30147368 DOI: 10.2147/cmar.s167560] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
3 Siregar GA, Irwansyah D. Comparison of Platelet to Lymphocyte Ratio between Degrees of the Barcelona Clinic Liver Cancer on Hepatocellular Carcinoma Patients at Haji Adam Malik General Hospital. Open Access Maced J Med Sci 2019;7:3451-4. [PMID: 32002072 DOI: 10.3889/oamjms.2019.444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Lu L, Zhang Y, Zheng P, Wu Z, Wang X, Chen Y, Chen X. Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study. J Hepatocell Carcinoma 2020;7:191-9. [PMID: 33117753 DOI: 10.2147/JHC.S274349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li M, Zhao Y, Liu X, Zhang S, Jiang Y, Yang Z. Early risk warning system for distant metastasis of hepatitis B virus-associated hepatocellular carcinoma with portal vein tumor thrombus. Oncol Lett 2020;19:3249-57. [PMID: 32256820 DOI: 10.3892/ol.2020.11423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Scheiner B, Kirstein M, Popp S, Hucke F, Bota S, Rohr-Udilova N, Reiberger T, Müller C, Trauner M, Peck-Radosavljevic M, Vogel A, Sieghart W, Pinter M. Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma. Liver Cancer 2019;8:203-17. [PMID: 31192156 DOI: 10.1159/000489833] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
7 Kang Z, Xiao E. Expression of cluster of differentiation 151 prior to and following transcatheter arterial chemoembolization therapy in patients with hepatocellular carcinoma and its association with clinicopathological characteristics. Oncol Lett 2018;15:1133-42. [PMID: 29391901 DOI: 10.3892/ol.2017.7371] [Reference Citation Analysis]
8 Aravalli RN, Steer CJ. Immune-Mediated Therapies for Liver Cancer. Genes (Basel) 2017;8:E76. [PMID: 28218682 DOI: 10.3390/genes8020076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
9 Pang Q, Qu K, Zhang J, Liu C. Application of the King's score as a prognostic model for hepatocellular carcinoma: still a long way to go. Liver Int 2016;36:764. [PMID: 25944407 DOI: 10.1111/liv.12864] [Reference Citation Analysis]
10 Lee CH, Chang CJ, Lin YJ, Yen CL, Shen CH, Cheng YT, Lin CC, Hsieh SY. Nomogram predicting extrahepatic metastasis of hepatocellular carcinoma based on commonly available clinical data. JGH Open. 2019;3:38-45. [PMID: 30834339 DOI: 10.1002/jgh3.12102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ozcelik F, Yiginer O, Özgün A. Relationship between thrombocytopenia and extrahepatic metastasis of hepatocellular carcinoma: a different perspective. Liver Int 2016;36:614-614. [DOI: 10.1111/liv.13062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Lai Q, Vitale A, Manzia TM, Foschi FG, Levi Sandri GB, Gambato M, Melandro F, Russo FP, Miele L, Viganò L, Burra P, Giannini EG; Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group. Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics. Cancers (Basel) 2019;11:E1568. [PMID: 31618961 DOI: 10.3390/cancers11101568] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Aryal B, Yamakuchi M, Shimizu T, Kadono J, Furoi A, Gejima K, Komokata T, Hashiguchi T, Imoto Y. Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma. Can J Gastroenterol Hepatol 2018;2018:9142672. [PMID: 30050894 DOI: 10.1155/2018/9142672] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
14 Gu J, Zhang X, Wang Z, Cui R, Zhang J, Jia Y, Miao R, Fan H, Wang H, Li Y, Zhang J, Liu C, Qu K. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery. Surg Oncol 2019;30:131-8. [PMID: 31500777 DOI: 10.1016/j.suronc.2019.07.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Cheng YQ, Wang K, Zhang XP, Wei XB, Jiang YB, Hu YR, Mao FF, Guo WX, Shi J, Cheng SQ. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy. J Gastroenterol Hepatol 2019;34:1214-21. [PMID: 30402968 DOI: 10.1111/jgh.14537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Dertli R, Asil M, Biyik M, Karakarcayildiz A, Keskin M, Göktepe HM, Kayar Y, Ataseven H. Can Hematological Inflammatory Parameters Predict Mortality in Hepatocellular Carcinoma? J Gastrointest Cancer 2021;52:666-75. [PMID: 32617832 DOI: 10.1007/s12029-020-00448-2] [Reference Citation Analysis]
17 Liu PH, Hsu CY, Su CW, Huang YH, Hou MC, Rich NE, Fujiwara N, Hoshida Y, Singal AG, Huo TI. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver Int 2020;40:2522-34. [PMID: 32511831 DOI: 10.1111/liv.14560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
18 Pang Q, Liu C, Qu K, Liu S. Conflicting relationship between platelets and prognosis of hepatocellular carcinoma: is platelet-derived serotonin involved in? Liver Int 2015;35:2484-2484. [DOI: 10.1111/liv.12843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
19 Deng Y, Pang Q, Miao RC, Chen W, Zhou YY, Bi JB, Liu SS, Zhang JY, Qu K, Liu C. Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma. Onco Targets Ther 2016;9:5317-28. [PMID: 27601923 DOI: 10.2147/OTT.S109736] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
20 Zhu B, Gu S, Wu X, He W, Zhou H. Bioinformatics analysis of tumor-educated platelet microRNAs in patients with hepatocellular carcinoma. Biosci Rep 2021;41:BSR20211420. [PMID: 34806748 DOI: 10.1042/BSR20211420] [Reference Citation Analysis]
21 Lisman T. Response to cautious use of platelet as relevant inducer of liver regeneration following partial hepatectomy in patients with metastatic hepatic carcinoma. Liver Int 2017;37:1918-9. [PMID: 29149488 DOI: 10.1111/liv.13463] [Reference Citation Analysis]
22 Pang Q, Liu S, Wang L, Pan H, Wang C, Zhou L, Lu Y, Liu H. The Significance of Platelet-Albumin-Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count. Cancer Manag Res 2020;12:12811-22. [PMID: 33364830 DOI: 10.2147/CMAR.S277013] [Reference Citation Analysis]
23 Lisman T, Luyendyk JP. Platelets as Modulators of Liver Diseases. Semin Thromb Hemost 2018;44:114-25. [PMID: 28898899 DOI: 10.1055/s-0037-1604091] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
24 Zhang Z, Zhang Y, Wang W, Hua Y, Liu L, Shen S, Peng B. Thrombocytopenia and the outcomes of hepatectomy for hepatocellular carcinoma: a meta-analysis. J Surg Res. 2017;210:99-107. [PMID: 28457347 DOI: 10.1016/j.jss.2016.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
25 Han S, Lee S, Yang JD, Leise MD, Ahn JH, Kim S, Jung K, Gwak MS, Kim GS, Ko JS. Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation. Liver Transpl. 2018;24:44-55. [PMID: 29024412 DOI: 10.1002/lt.24961] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
26 Yang Q, Liu S, Deng C, Shu B, Zhang J, Zhai M. Preoperative Serum and Intra-platelet Serotonin in Prognosis: Useful or Useless? J Cancer 2018;9:3713-4. [PMID: 30405841 DOI: 10.7150/jca.27497] [Reference Citation Analysis]
27 Lai Q, Melandro F, Larghi Laureiro Z, Giovanardi F, Ginanni Corradini S, Ferri F, Hassan R, Rossi M, Mennini G. Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis. World J Gastroenterol 2018; 24(15): 1658-1665 [PMID: 29686473 DOI: 10.3748/wjg.v24.i15.1658] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
28 Han S. Possible roles of platelets in liver transplantation: regeneration and cancer recurrence. Anesth Pain Med (Seoul) 2021;16:225-31. [PMID: 34352964 DOI: 10.17085/apm.21063] [Reference Citation Analysis]
29 Lu L, Su Z, Zheng P, Wu Z, Zhang Y, He H, Liu J, Lin S, Chen X. Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study. BMJ Open 2020;10:e038172. [PMID: 33158820 DOI: 10.1136/bmjopen-2020-038172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Pang Q, Zhang JY, Liu SS, Liu C. Adverse effects of platelets on post-hepatectomy outcomes in patients with hepatocellular carcinoma. J Hepatol 2016;64:518-9. [PMID: 26551517 DOI: 10.1016/j.jhep.2015.10.026] [Reference Citation Analysis]
31 Omran MM, Mosaad S, Emran TM, Eltaweel FM, Farid K. A novel model based on interleukin 6 and insulin-like growth factor II for detection of hepatocellular carcinoma associated with hepatitis C virus. J Genet Eng Biotechnol 2021;19:168. [PMID: 34714420 DOI: 10.1186/s43141-021-00262-8] [Reference Citation Analysis]
32 Hsieh SY, Lee CH, Lin CC. Platelet: A friend or foe of patients with hepatoma? Liver Int 2016;36:615. [PMID: 27005697 DOI: 10.1111/liv.13093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]